Vous êtes ici

Treatment.com AI Inc.

Treatment.com AI Inc.
Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Technology
Symbole: 
TRUE
Indice CSE: 
Devise: 

Treatment.com AI has created the world’s most intelligent, personalized healthcare AI engine, Global Library of Medicine (GLM). Utilizing proprietary algorithms, GLM is the most comprehensive and integrated online medical library powered by AI. GLM provides the highest qualified clinical information and support to all Healthcare Professionals, with a > 90%+ accuracy on first diagnosis. The platform has been curated and evaluated by hundreds of credentialed physicians globally and supports more than 1,000 diseases & >10,000 symptoms and risk factors. 

 

Treatment.com AI’s Medical Education Suite (MES) is being utilized by Medical and Nursing Schools to support the next generation of healthcare professionals. The benefit to Schools is reduced administrative time, resources and costs, as well ensuring a consistent approach to assess clinical skills and scoring for national exams (OSCE). For students, MES enables an opportunity to practice and take remedial actions ahead of final exams.

Vous êtes ici

Treatment.com AI Inc. (TRUE)

SEDAR Information

Information d'entreprise

Addresse
2630 Croydon Dr.
Unit 217
Surrey, BC V3S 0B7
Canada
Téléphone
612-788-8900
Courriel
info@treatment.com
URL
http://www.treatment.com
Date d’inscription à la cote
Lundi, avril 19, 2021
Agent de transfert
National Securities Administrators Ltd.

Capitalisation

Capitalisation: 
39223518
Réservé à l'émission: 
11661920

Company Officers

Kevin Peterson, Chairman
Kelly Pladson, Corporate Secretary
Essam Hamza, CEO
David Worner, CFO
Richard Atkins, Chief Operating Officer

Bulletins

07/11/2023

2023-1105 - Changement de Nom - Treatment.com International Inc. (TRUE)

le 7 novembre/November 2023

Treatment.com International Inc. has announced a name change to Treatment.com AI Inc.

Shares will begin trading under the new name and with a new CUSIP number on November 9, 2023.

The symbol will remain the same.

Disclosure documents are available at www.thecse.com.